• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JCI Insight . Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2

tetano

Editor, Senior Moderator
JCI Insight


. 2022 Sep 22;7(18):e158308.
doi: 10.1172/jci.insight.158308.
Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2


Worarat Chaisawangwong[SUP] 1 [/SUP], Hanzhi Wang[SUP] 2 [/SUP], Theodore Kouo[SUP] 3 [/SUP], Sebastian F Salathe[SUP] 1 [/SUP], Ariel Isser[SUP] 4 5 [/SUP], Joan Glick Bieler[SUP] 1 [/SUP], Maya L Zhang[SUP] 2 [/SUP], Natalie K Livingston[SUP] 4 [/SUP], Shuyi Li[SUP] 1 [/SUP], Joseph J Horowitz[SUP] 6 [/SUP], Ron E Samet[SUP] 7 [/SUP], Israel Zyskind[SUP] 8 [/SUP], Avi Z Rosenberg[SUP] 1 [/SUP], Jonathan P Schneck[SUP] 1 4 5 9 10 [/SUP]



Affiliations

Abstract

Cross-reactive immunity between SARS-CoV-2 and other related coronaviruses has been well-documented, and it may play a role in preventing severe COVID-19. Epidemiological studies early in the pandemic showed a geographical association between high influenza vaccination rates and lower incidence of SARS-CoV-2 infection. We, therefore, analyzed whether exposure to influenza A virus (IAV) antigens could influence the T cell repertoire in response to SARS-CoV-2, indicating a heterologous immune response between these 2 unrelated viruses. Using artificial antigen-presenting cells (aAPCs) combined with real-time reverse-transcription PCR (RT-qPCR), we developed a sensitive assay to quickly screen for antigen-specific T cell responses and detected a significant correlation between responses to SARS-CoV-2 epitopes and IAV dominant epitope (M158-66). Further analysis showed that some COVID-19 convalescent donors exhibited both T cell receptor (TCR) specificity and functional cytokine responses to multiple SARS-CoV-2 epitopes and M158-66. Utilizing an aAPC-based stimulation/expansion assay, we detected cross-reactive T cells with specificity to SARS-CoV-2 and IAV. In addition, TCR sequencing of the cross-reactive and IAV-specific T cells revealed similarities between the TCR repertoires of the two populations. These results indicate that heterologous immunity shaped by our exposure to other unrelated endemic viruses may affect our immune response to novel viruses such as SARS-CoV-2.

Keywords: Adaptive immunity; COVID-19; Immunology; T cells.
 
Back
Top Bottom